News
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...
The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to ...
With the recent establishment in India of more innovative biotech companies 1, a small number of personnel have started to work on novel programs, which has led to the nurturing of new sets of skills.
During a U.S. House budget hearing, Health Secretary RFK Jr. accused Rep. Frank Pallone Jr. of accepting $2 million from ...
The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record ...
India's obesity drug market is set for intense competition with Novo Nordisk launching Wegovy to challenge Eli Lilly's ...
Novo Nordisk launches Wegovy® in India, a weight management therapy reducing cardiovascular risks for people with obesity.
The drug works by acting on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, ...
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy as a once-a-week injection in India ...
Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...
The Danish company has introduced five dosage options for its self-injectable weight-loss drug, with variable monthly pricing for the higher strengths.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results